FOLH1 | Folate hydrolase (prostate-specific membrane antigen) 1 | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
FRK | Fyn-related Src family tyrosine kinase | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Mixed |
FSHR | Follicle stimulating hormone receptor | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Group enriched |
FTH1 | Ferritin, heavy polypeptide 1 | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
FTL | Ferritin, light polypeptide | Cancer-related genes Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
FXYD2 | FXYD domain containing ion transport regulator 2 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
GAA | Glucosidase, alpha; acid | Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
GABBR1 | Gamma-aminobutyric acid (GABA) B receptor, 1 | FDA approved drug targets G-protein coupled receptors Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
GABBR2 | Gamma-aminobutyric acid (GABA) B receptor, 2 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Tissue enriched |
GABRA1 | Gamma-aminobutyric acid (GABA) A receptor, alpha 1 | Disease related genes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
GABRA2 | Gamma-aminobutyric acid (GABA) A receptor, alpha 2 | FDA approved drug targets Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
GABRA3 | Gamma-aminobutyric acid (GABA) A receptor, alpha 3 | FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enriched |
GABRA4 | Gamma-aminobutyric acid (GABA) A receptor, alpha 4 | FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enriched |
GABRA5 | Gamma-aminobutyric acid (GABA) A receptor, alpha 5 | FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
GABRA6 | Gamma-aminobutyric acid (GABA) A receptor, alpha 6 | FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Not detected |
GABRB1 | Gamma-aminobutyric acid (GABA) A receptor, beta 1 | FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
GABRB2 | Gamma-aminobutyric acid (GABA) A receptor, beta 2 | FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
GABRB3 | Gamma-aminobutyric acid (GABA) A receptor, beta 3 | Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
GABRD | Gamma-aminobutyric acid (GABA) A receptor, delta | Disease related genes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enriched |
GABRE | Gamma-aminobutyric acid (GABA) A receptor, epsilon | FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
GABRG1 | Gamma-aminobutyric acid (GABA) A receptor, gamma 1 | FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enriched |
GABRG2 | Gamma-aminobutyric acid (GABA) A receptor, gamma 2 | Disease related genes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enriched |
GABRG3 | Gamma-aminobutyric acid (GABA) A receptor, gamma 3 | FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
GABRP | Gamma-aminobutyric acid (GABA) A receptor, pi | FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
GABRQ | Gamma-aminobutyric acid (GABA) A receptor, theta | FDA approved drug targets Predicted membrane proteins
| | | | | Group enriched |
GABRR1 | Gamma-aminobutyric acid (GABA) A receptor, rho 1 | FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
GABRR2 | Gamma-aminobutyric acid (GABA) A receptor, rho 2 | FDA approved drug targets Predicted membrane proteins
| | | | | Not detected |
GABRR3 | Gamma-aminobutyric acid (GABA) A receptor, rho 3 (gene/pseudogene) | FDA approved drug targets Predicted membrane proteins
| | | | | Not detected |
GALNT8 | Polypeptide N-acetylgalactosaminyltransferase 8 | Enzymes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins Voltage-gated ion channels
| | | | | Tissue enhanced |
GAMT | Guanidinoacetate N-methyltransferase | Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
GANAB | Glucosidase, alpha; neutral AB | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
GANC | Glucosidase, alpha; neutral C | Enzymes FDA approved drug targets Predicted intracellular proteins
| | | | | Expressed in all |
GART | Phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
GCGR | Glucagon receptor | FDA approved drug targets G-protein coupled receptors Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
GGCX | Gamma-glutamyl carboxylase | Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Expressed in all |
GGPS1 | Geranylgeranyl diphosphate synthase 1 | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
GHR | Growth hormone receptor | Disease related genes FDA approved drug targets Predicted membrane proteins
| | | | | Group enriched |
GHRHR | Growth hormone releasing hormone receptor | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Not detected |
GLP1R | Glucagon-like peptide 1 receptor | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
GLP2R | Glucagon-like peptide 2 receptor | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
GLRA1 | Glycine receptor, alpha 1 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Not detected |
GLRA2 | Glycine receptor, alpha 2 | FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
GLRA3 | Glycine receptor, alpha 3 | FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
GLRB | Glycine receptor, beta | Disease related genes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enhanced |
GNRHR | Gonadotropin-releasing hormone receptor | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
GRIA1 | Glutamate receptor, ionotropic, AMPA 1 | FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Tissue enriched |
GRIK1 | Glutamate receptor, ionotropic, kainate 1 | FDA approved drug targets Predicted membrane proteins
| | | | | Group enriched |
GRIN1 | Glutamate receptor, ionotropic, N-methyl D-aspartate 1 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins Transporters
| | | | | Tissue enriched |
GRIN2A | Glutamate receptor, ionotropic, N-methyl D-aspartate 2A | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Tissue enriched |
GRIN2B | Glutamate receptor, ionotropic, N-methyl D-aspartate 2B | Disease related genes FDA approved drug targets Predicted membrane proteins RAS pathway related proteins
| | | | | Tissue enriched |